Clinical Trials
9 trialsNCT06566209 2026-05-08
FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis
Mayo Clinic
Terminated
NCT04504331 2026-02-12
Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer
Stanford University
Phase 1 Terminated
NCT03053960 2025-04-30
Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer
Thomas Jefferson University
Terminated
NCT02922283 2024-05-06
IL2 Imaging in Metastatic Melanoma
University Medical Center Groningen
Phase NA Terminated
NCT02809690 2023-09-07
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
University of Southern California
Phase 1 Terminated
NCT04282694 2021-11-19
PSP
University of Parma
Terminated
NCT02388932 2019-01-24
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer
Case Comprehensive Cancer Center
Phase NA Terminated
NCT02708511 2018-04-05
Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer
Stanford University
Phase 1 Terminated
NCT02236546 2017-04-13
FDG-PET in Advanced Melanoma
Vanderbilt-Ingram Cancer Center
Phase NA Terminated